Cures Welcome at FDA – WSJ

0
146
DOWNLOAD THE APP



Few conditions are as wrenching as the destruction of memory known as Alzheimer’s, and few diseases have so eluded drug companies and researchers looking for a cure. So it’s welcome news that the Food and Drug Administration is inviting more innovation, and more broadly revamping the agency’s review process.

FDA recently updated its scientific thinking on early Alzheimer’s, along with other neurological conditions, and this matters because such draft guidance informs industry and academic efforts. One reality of Alzheimer’s…



Source link

READ  North Korea Ready to Discuss Denuclearization, U.S. Officials Say
GET ACCESS TO FREE TRAINING NOW

LEAVE A REPLY

Please enter your comment!
Please enter your name here